Purdue Pharma, the Connecticut-based pharmaceutical company owned by the Sackler family, brought OxyContin to market in 1995. The Sacklers dismissed warnings that the drug was addictive and unleashed a well-funded marketing campaign to sell it to doctors. Since then, Purdue Pharma and the Sacklers have been sued thousands of times for the role they played in the opioid epidemic, and now some fifteen hundred civil cases against the company and its founders have been bundled together into a multi-district litigation that could cost the Sacklers billions of dollars. Patrick Radden Keefe joins Dorothy Wickenden to discuss how the Sackler family and Purdue Pharma participated in the proliferation of opioids and what the new round of lawsuits may mean for the company’s future.

The Sackler Family, Purdue Pharma, and the Lawsuits Threatening Opioid Manufacture

Join The New Yorker’s writers and editors for reporting, insight, and analysis of the most pressing political issues of our time. On Mondays, David Remnick, the editor of The New Yorker, presents conversations and feature stories about current events. On Wednesdays, the senior editor Tyler Foggatt goes deep on a consequential political story via far-reaching interviews with staff writers and outside experts. And, on Fridays, the staff writers Susan B. Glasser, Jane Mayer, and Evan Osnos discuss the latest developments in Washington and beyond, offering an encompassing understanding of this moment in American politics.

News

Politics

Both anecdotally and in research, anxiety and depression among young people—often associated with self-harm—have risen sharply over the last decade. There seems little doubt that Gen Z is suffering in real ways. But there is not a consensus on the cause or causes, nor how to address them. The social psychologist Jonathan Haidt believes that enough evidence has accumulated to convict a suspect. Smartphones and social media, Haidt says, have caused a “great rewiring” in those born after 1995. The argument has hit a nerve: his new book, “The Anxious Generation,” was No. 1 on the New York *Times* hardcover nonfiction best-seller list. Speaking with David Remnick, Haidt is quick to differentiate social-media apps—with their constant stream of notifications, and their emphasis on performance—from technology writ large; mental health was not affected, he says, for millennials, who grew up earlier in the evolution of the Internet. Haidt, who earlier wrote about an excessive emphasis on safety in the book “The Coddling of the American Mind,” feels that our priorities when it comes to child safety are exactly wrong. “We’re overprotecting in [the real world], and I’m saying, lighten up, let your kids out! And we’re underprotecting in another, and I’m saying, don’t let your kids spend nine hours a day on the Internet talking with strange men. It’s just not a good idea.” To social scientists who have asserted that the evidence Haidt marshals does not prove a causative link between social media and depression, “I keep asking for alternative theories,” he says. “You don’t think it’s the smartphones and social media—what is it?&nbsp;.&nbsp;.&nbsp;. You can give me whatever theory you want about trends in American society, but nobody can explain why it happened so suddenly in 2012 and 2013—not just here but in Canada, the U.K., Australia, New Zealand, Northern Europe. I’m waiting,” he adds sarcastically, “for someone to find a chemical.” The good news, Haidt says, is there are achievable ways to limit the harm.Note: In his conversation with David Remnick, Jonathan Haidt misstated some information about a working paper that studies unhappiness across nations. The authors are David G. Blanchflower, Alex Bryson, and Xiaowei Xu, and it includes data on thirty-four countries.

Jonathan Haidt on “The Anxious Generation”

The Washington Roundtable: Susan B. Glasser, Jane Mayer, and Evan Osnos talk with the NPR reporter Andrea Bernstein about what has happened inside the courthouse during Donald Trump’s first week on trial. Plus, how the historic trial may factor into the 2024 race and whether President Biden should be talking about it on the campaign trail.“This idea of the old ‘Teflon Don’ is just finished,” Evan Osnos says. “The guy is now a creature of the court.”This week’s reading:
“Donald Trump’s Trial of the Century,” by Eric Lach
“The Supreme Court Asks What Enron Has to Do with January 6th—and Trump,” by Amy Davidson Sorkin
“Biden Is the Most Pro-Labor President Since F.D.R. Will It Matter in November?,” by Eyal Press
“Did Mike Johnson Just Get Religion on Ukraine?,” by Susan B. Glasser
To discover more podcasts from The New Yorker, visit newyorker.com/podcasts. To send feedback on this episode, write to themail@newyorker.com with “The Political Scene” in the subject line.

The Morality Play Inside Trump’s Courtroom

Ronan Farrow, a Pulitzer Prize-winning investigative reporter and contributing writer to The New Yorker, joins Tyler Foggatt to discuss the impact of rulings made this week by Judge Juan Merchan in Donald Trump’s criminal trial in New York, where he faces thirty-four felony counts for falsifying business records related to hush-money payments made to adult-film star Stormy Daniels around the time of the 2016 election. Farrow explains why two other hush-money payments, made to former Trump Tower doorman Dino Sajudin and former Playboy model Karen McDougal, are central to the Manhattan District Attorney’s case. As Farrow explains, “the coverup is ultimately a much, much bigger story than any of the underlying things being covered up would have been.”This week’s reading:

Inside the Hush-Money Payments That May Decide Trump’s Legal Fate, by Ronan Farrow

The National Enquirer, a Trump Rumor, and Another Secret Payment to Buy Silence, by Ronan Farrow

Donald Trump, a Playboy Model, and a System for Concealing Infidelity, by Ronan Farrow
To discover more podcasts from The New Yorker, visit newyorker.com/podcasts. To send feedback on this episode, write to themail@newyorker.com.

Ronan Farrow on the Scheme at the Heart of Trump’s New York Trial

Texas has multiple abortion laws, with both criminal and civil penalties for providers. They contain language that may allow for exceptions to save the life or “major bodily function” of a pregnant patient, but many doctors have been reluctant to even try interpreting these laws; at least one pregnant woman has been denied cancer treatment. The reporter Stephania Taladrid tells David Remnick about how two lawmakers worked together in a rare bipartisan effort to clarify the limited medical circumstances in which abortion is allowed. “If lawmakers created specific exemptions,” Taladrid explains, “then doctors who got sued could show that the treatment that they had offered their patients was compliant with the language of the law.” Taladrid spoke with the state representatives Ann Johnson, a Democrat, and Bryan Hughes, a conservative Republican, about their unlikely collaboration. Johnson told her that she put together a list of thirteen conditions that might qualify for a special exemption, but only two of them—premature ruptures and ectopic pregnancy—were cited in the final bill. Still, the unusual bipartisan action is cause for hope among reproductive-rights advocates that some of the extreme climate around abortion bans may be lessening.

A Bipartisan Effort to Carve out Exemptions to Texas’s Abortion Ban

The Washington Roundtable: Susan B. Glasser, Jane Mayer, and Evan Osnos discuss the revival of Arizona’s hundred-and-sixty-year-old abortion ban, what role the issue of reproductive freedom will play in the November election, and how the position of reproductive health care in politics has evolved over the decades.This week’s reading:
“Donald Trump Did This,” by Susan B. Glasser
“The Fight to Restore Abortion Rights in Texas,” by Stephania Taladrid
To discover more podcasts from The New Yorker, visit newyorker.com/podcasts. To send feedback on this episode, write to themail@newyorker.com with “The Political Scene” in the subject line.

The Sackler Family, Purdue Pharma, and the Lawsuits Threatening Opioid Manufacture

Download our free app to listen on your phone